What Happened?
Westminster, CO-based TriSalus Life Sciences Appointed James Alecxih as President of Device Technology Business
About the Company
TriSalus Life Sciences is dedicated to improving patient outcomes in pancreatic and other highly intractable solid tumors. TriSalus Infusion Systems, powered by the proprietary Pressure-Enabled Drug Delivery (PEDD) approach with SmartValve technology have the potential to improve the delivery and distribution of diagnostic agents, therapeutics, and immuno-stimulants into the tumor vasculature.
About the Person
James Alecxih is President of Device Technology Business at TriSalus Life Sciences. Previously, James held various senior IT leadership roles in the industry.
Info Source
News
Short Profile